» Articles » PMID: 25913460

Overweight, Diabetes and Disease Duration Influence Clinical Severity in Hidradenitis Suppurativa-acne Inversa: Evidence from the National Italian Registry

Overview
Journal Br J Dermatol
Specialty Dermatology
Date 2015 Apr 28
PMID 25913460
Citations 28
Authors
Affiliations
Soon will be listed here.
Citing Articles

Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).

Daoud M, Benhadou F, Suppa M, Sarkis A, Heudens S, Desmarest L Arch Dermatol Res. 2025; 317(1):189.

PMID: 39775946 DOI: 10.1007/s00403-024-03675-w.


Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?.

Strong J, Driscoll M Am J Clin Dermatol. 2024; 26(2):175-182.

PMID: 39690371 DOI: 10.1007/s40257-024-00911-x.


Evidence of a Causal Relationship Between Body Mass Index and Immune-Mediated and Inflammatory Skin Diseases and Biomarkers: A Mendelian Randomization Study.

Li Z, Zhao Y Clin Cosmet Investig Dermatol. 2024; 17:2659-2667.

PMID: 39606276 PMC: 11600962. DOI: 10.2147/CCID.S496066.


Hidradenitis suppurativa and its association with obesity, smoking, and diabetes mellitus: A systematic review and meta-analysis.

Elzawawi K, Elmakaty I, Habibullah M, Ahmed M, Al Lahham S, Al Harami S Int Wound J. 2024; 21(9):e70035.

PMID: 39267324 PMC: 11393007. DOI: 10.1111/iwj.70035.


Improving hidradenitis suppurativa management: consensus statements from physicians and patients' perspectives.

Marzano A, Magnoni C, Micali G, de Magnis A, Pintori G, Fiorini S Arch Dermatol Res. 2024; 316(8):577.

PMID: 39180694 PMC: 11344722. DOI: 10.1007/s00403-024-03316-2.